U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H10O2
Molecular Weight 90.121
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1,2-DIMETHOXYETHANE

SMILES

COCCOC

InChI

InChIKey=XTHFKEDIFFGKHM-UHFFFAOYSA-N
InChI=1S/C4H10O2/c1-5-3-4-6-2/h3-4H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C4H10O2
Molecular Weight 90.121
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Diabetic vitreopapillary traction and macular oedema.
2005-06
Mass spectrometric investigation of noncovalent complexation between a tetratosylated resorcarene and alkyl ammonium ions.
2004-11-19
The effect of molecular crowding with nucleotide length and cosolute structure on DNA duplex stability.
2004-11-10
Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
2004-11
Impact of a program to provide patients with comparative information about providers of durable medical equipment for home respiratory care.
2004-11
The Department of Medical Education at the University of Michigan Medical School: a case study in medical education research productivity.
2004-10
Socioeconomic disparities in the use of home health services in a medicare managed care population.
2004-10
The coordination chemistry of "[BP3]NiX" platforms: targeting low-valent nickel sources as promising candidates to L3Ni=E and L3Ni(triple bond)E linkages.
2004-07-26
Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life.
2004-07
Armadillo/beta-catenin-dependent Wnt signalling is required for the polarisation of epidermal cells during dorsal closure in Drosophila.
2004-07
[Failure of photocoagulation therapy for diabetic macular edema].
2004-06
Enhanced TARC production by dust-mite allergens and its modulation by immunosuppressive drugs in PBMCs from patients with atopic dermatitis.
2004-06
A cell-based system to identify and characterize the molecular mechanism of drug-metabolizing enzyme (DME) modulators.
2004-05-15
Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.
2004-05
Reactions of lanthanoid metals with 3,5-diphenylpyrazole at elevated temperatures: synthesis and structures of both homoleptic, [Ln3(Ph2pz)9] (Ln = La, Nd), [Ln2(Ph2pz)6] (Ln = Er, Lu), and heteroleptic, [Ln(Ph2pz)3(Ph2pzH)2] (Ln = La, Nd, Gd, Tb, Er or Yb), pyrazolate complexes.
2004-04-21
Services provided following compensable work-related tetraplegia.
2004-04
Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography.
2004-04
Dimethylethanolamine does not prevent liver failure in phosphatidylethanolamine N-methyltransferase-deficient mice fed a choline-deficient diet.
2004-03-22
Elevated-temperature metathesis syntheses of structurally novel alkali-metal tetrakis(3,5-di-tert-butylpyrazolato)lanthanoidate(III) complexes: toluene-coordinated discrete bimetallic complexes and supramolecular chains.
2004-03-05
Quantitative study of spongiform change in putamen of 24 cases of Creutzfeldt-Jakob disease.
2004-03
Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.
2004-02
Supplemental oxygen improves diabetic macular edema: a pilot study.
2004-02
Comparison of Heidelberg Retina Tomograph II and Retinal Thickness Analyzer in the assessment of diabetic macular edema.
2004-02
Experimental validation of theoretical potassium and sodium cation affinities of amides by mass spectrometric kinetic method measurements.
2004
Diferratricarbaboranes of the subcloso-[(eta5-C5H5)2Fe2C3B8H11] type, the first representatives of the 13-vertex dimetallatricarbaborane series.
2003-12-15
Diabetic macular edema: classification, medical and laser therapy.
2003-12
Polarographic determination of ciclopirox olamine in pure substance and in different pharmaceutical preparations.
2003-12
Acid-base equilibria in nonpolar media. 3. Expanding the spectrophotometric acidity scale in heptane.
2003-10-03
Synthesis of 3-(alpha- and beta-D-arabinofuranosyl)-6-chloro-1,2,4-triazolo[4,3-b]pyridazine.
2003-09-26
Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
2003-09
Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.
2003-09
Acid pH increases the stability of BSC1/NKCC2 mRNA in the medullary thick ascending limb.
2003-09
Alcohols, ethers, carbohydrates, and related compounds. III. The 1,2-dimethoxyethane system.
2003-09
Group 6 imido complexes supported by diamido-donor ligands.
2003-08-11
Polar organic solvent added to an aqueous solution changes hydrolytic property of lipase.
2003-08
Studies on osteogenic differentiation of rat bone marrow stromal cells cultured in type I collagen gel by RT-PCR analysis.
2003-08
Crystals from concentrated glyme mixtures. The single-crystal structure of LiClO4.
2003-07-28
Effects of two vitamins, two growth factors and dexamethasone on the proliferation of rat bone marrow stromal cells and osteoblastic MC3T3-E1 cells.
2003-07
Aromatic hydrocarbon-catalyzed direct reaction of sulfur and sodium in a heterogeneous system: selective and facile synthesis of sodium monosulfide and disulfide.
2003-06-16
Nucleophilic epoxidation of gamma-hydroxyvinyl sulfoxide derivatives.
2003-06-13
Role of OCT in the diagnosis and follow up of diabetic macular edema.
2003-06
Tin(II) chloride catalyzed reactions of diazodiphenylmethane with vicinal diols in an aprotic solvent. The reactions with cis- and trans-1,2-cyclohexanediols and 1,2-propanediol.
2003-04-22
Tumoral drug metabolism: perspectives and therapeutic implications.
2003-04
Synthesis of 2'-C-beta-fluoromethyluridine.
2003-03-20
Relation of diabetic macular edema to cytokines and posterior vitreous detachment.
2003-03
Polarographic behavior and determination of finasteride.
2003-02
[Non-insulin-dependent diabetes: an expanding disease. Diabetic ophthalmopathy: diabetic retinopathy facts].
2003
Comparing differentiation of xylene isomers by electronic ionization, chemical ionization and self-ion/molecule reactions and the first observation of methyne addition ions for xylene isomers in self-ion/molecule reactions for non-nitrogenated compounds.
2003
Direct magnitude estimation and interval scaling of hypernasality.
2002-02
[Application of direct fluorescence technique in the diagnosis of superficial mycosis ].
2002
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:44:31 GMT 2025
Edited
by admin
on Mon Mar 31 18:44:31 GMT 2025
Record UNII
GXS24JF5IW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-60542
Preferred Name English
1,2-DIMETHOXYETHANE
HSDB   MI  
Systematic Name English
1,2-DIMETHOXYETHANE [MI]
Common Name English
.ALPHA.,.BETA.-DIMETHOXYETHANE
Systematic Name English
DIMETHYOXYETHANE, 1,2-
Common Name English
1,2-DIMETHOXYETHANE [HSDB]
Common Name English
ETHYLENE GLYCOL DIMETHYL ETHER
Systematic Name English
1,2-DIMETHOXYETHANE [USP-RS]
Common Name English
MONOGLYME
Systematic Name English
GLYME
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
203-794-9
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
MERCK INDEX
m4515
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY Merck Index
WIKIPEDIA
1,2-Dimethoxyethane
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
HSDB
73
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
RS_ITEM_NUM
1601463
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
CAS
110-71-4
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
FDA UNII
GXS24JF5IW
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
CHEBI
42263
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
NSC
60542
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
PUBCHEM
8071
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
SMS_ID
300000052914
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID0025286
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY
DRUG BANK
DB01749
Created by admin on Mon Mar 31 18:44:31 GMT 2025 , Edited by admin on Mon Mar 31 18:44:31 GMT 2025
PRIMARY